Always on the hunt for promising innovations, we are now applying two new groundbreaking diagnostic technologies to the problem of detecting clinical evidence of slow-growing, elusive, low abundance infections. In addition to BAPGM™ enrichment, Nanotrap® particle enrichment and droplet digital PCR (ddPCR) offer significant promise for improved direct detection of low-abundance pathogens like Bartonella and Borrelia species. More sensitive and specific detection supports earlier diagnosis and earlier diagnosis means better treatment response in the field of infectious disease.

We also identify as a “One Health” company. The One Health perspective recognizes that human, animal, and environmental health are all connected. In fact, six of every 10 infectious diseases in humans are spread from animals. The goal of One Health is to encourage the collaborative efforts of multiple disciplines working locally, nationally, and globally to achieve the best health for people, animals, and our environment. Our company was spun out of the North Carolina State College of Veterinary Medicine and has ongoing collaborations with physicians, veterinarians, microbiologists, clinical chemists, patients, and disease advocates in many fields to generate new understandings about the importance of flea- and tick-borne disease for global health. We encourage you to learn more about the One Health Initiative and to look beyond the boundaries of human health to better understand health impacts around the globe.

Galaxy Diagnostics, Inc. products

Galaxy - Bartonella Digital ePCR Technologies